AMPK Activation through Mitochondrial Regulation Results in Increased Substrate Oxidation and Improved Metabolic Parameters in Models of Diabetes

Yonchu Jenkins(Rigel (United States)), Tian‐Qiang Sun(Rigel (United States)), Vadim Markovtsov(Rigel (United States)), Marc Foretz(Délégation Paris 5), Wei Li(Rigel (United States)), Henry Nguyen(Rigel (United States)), Yingwu Li(Rigel (United States)), Alison Pan(Rigel (United States)), Gerald Uy(Rigel (United States)), Lisa Groß(Rigel (United States)), Kristen A. Baltgalvis(Rigel (United States)), Stephanie Yung(Rigel (United States)), Tarikere Gururaja(Rigel (United States)), Taisei Kinoshita(Rigel (United States)), Alexander M. Owyang(Rigel (United States)), Ira J. Smith(Rigel (United States)), Kelly McCaughey(Rigel (United States)), Kathy White(Rigel (United States)), Guillermo Godinez(Rigel (United States)), Raniel Alcantara(Rigel (United States)), Carmen Choy(Rigel (United States)), Hongqiang Ren(Rigel (United States)), Rachel Basile(Rigel (United States)), David J. Sweeny(Rigel (United States)), Xiang Xu(Rigel (United States)), Sarkiz D. Issakani(Rigel (United States)), D. C. Carroll(Rigel (United States)), Dane A. Goff(Rigel (United States)), Simon J. Shaw(Rigel (United States)), Rajinder Singh(Rigel (United States)), László G. Boros(The Lundquist Institute), Marc‐André Laplante(Institut universitaire de cardiologie et de pneumologie de Québec), Bruno Marcotte(Institut universitaire de cardiologie et de pneumologie de Québec), Rita Kohen(Institut universitaire de cardiologie et de pneumologie de Québec), Benoı̂t Viollet(Délégation Paris 5), André Marette(Institut universitaire de cardiologie et de pneumologie de Québec), Donald G. Payan(Rigel (United States)), Todd M. Kinsella(Rigel (United States)), Yasumichi Hitoshi(Rigel (United States))
PLoS ONE
December 5, 2013
Cited by 56Open Access
Full Text

Abstract

Modulation of mitochondrial function through inhibiting respiratory complex I activates a key sensor of cellular energy status, the 5'-AMP-activated protein kinase (AMPK). Activation of AMPK results in the mobilization of nutrient uptake and catabolism for mitochondrial ATP generation to restore energy homeostasis. How these nutrient pathways are affected in the presence of a potent modulator of mitochondrial function and the role of AMPK activation in these effects remain unclear. We have identified a molecule, named R419, that activates AMPK in vitro via complex I inhibition at much lower concentrations than metformin (IC50 100 nM vs 27 mM, respectively). R419 potently increased myocyte glucose uptake that was dependent on AMPK activation, while its ability to suppress hepatic glucose production in vitro was not. In addition, R419 treatment of mouse primary hepatocytes increased fatty acid oxidation and inhibited lipogenesis in an AMPK-dependent fashion. We have performed an extensive metabolic characterization of its effects in the db/db mouse diabetes model. In vivo metabolite profiling of R419-treated db/db mice showed a clear upregulation of fatty acid oxidation and catabolism of branched chain amino acids. Additionally, analyses performed using both (13)C-palmitate and (13)C-glucose tracers revealed that R419 induces complete oxidation of both glucose and palmitate to CO2 in skeletal muscle, liver, and adipose tissue, confirming that the compound increases mitochondrial function in vivo. Taken together, our results show that R419 is a potent inhibitor of complex I and modulates mitochondrial function in vitro and in diabetic animals in vivo. R419 may serve as a valuable molecular tool for investigating the impact of modulating mitochondrial function on nutrient metabolism in multiple tissues and on glucose and lipid homeostasis in diabetic animal models.


Related Papers

No related papers found

Powered by citation graph analysis